港交所(00388.HK)将向已接种两剂疫苗香港员工提供额外两天年假
港交所(00388.HK)表示,全力支持全球疫苗接种,以应对新型冠状病毒疫情,将向在香港工作并已接种两剂新型冠状病毒疫苗的员工提供额外两天年假,以肯定他们对社区健康的贡献和支持香港政府推行的疫苗接种计划。
港交所集团行政总裁欧冠升表示,接种疫苗是全球抗疫的最佳方法。港交所的运作对於维护香港作为国际金融中心的地位十分关键,集团一直努力确保旗下的市场能在疫情期间维持稳健及有效运作,将继续竭尽所能,协助香港与全球金融业界尽早回复正常的联通及交流。
港交所呼吁公司同事和其他能够接种疫苗的人士尽快接种疫苗,并称重视员工的健康和安全,会继续密切留意事态发展,必要时将重新审视相关安排。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.